Proentry peptide
Reduce allergic asthma inflammation in the body
Mr. M, a 73-year-old alcoholic who has been suffering from hepatitis C and cirrhosis, was diagnosed with advanced hepatocellular carcinoma in August 2019. After receiving microwave ablation, interventional therapy, and taking various treatment options such as lenvatinib , the condition has not improved significantly, and the lesions on the liver are already as big as duck eggs (65mm). In September 2021, Mr. M was fortunate enough to be enrolled in the clinical trial of the GNOS-PV02 vaccine and received this new combination therapy.
What shocked everyone was that the lesions shrank significantly after only 9 weeks of treatment. After 27 weeks, imaging examinations showed that the lesions on his liver had disappeared, and the response reached complete remission (CR)! [:%%]
住戶編號:2993626
檢舉原因
心情: 
